Nasdaq
ENGN
enGene Therapeutics Inc.
- Health Care
- Canada
- 1 day
- +0.0%
- 1 month
- −6.3%
- 1 year
- −53.6%
$1.80 · Mkt cap $121M
At the 6 Aug 2026 close
Nasdaq
enGene Therapeutics Inc.
$1.80 · Mkt cap $121M
At the 6 Aug 2026 close
enGene Therapeutics Inc. trades under the ticker ENGN on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $121M. The last closing price was $1.80, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −53.6%, and −6.3% over the past month. Returns are price returns and exclude dividends.
This page exists because ENGN is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.